WebFind the latest Financials data for Jasper Therapeutics, Inc. Common Stock (JSPR) at Nasdaq.com. Web31 ian. 2024 · Jasper Therapeutics, Inc. is a clinical-stage biotechnology company developing briquilimab, a monoclonal antibody targeting c-Kit (CD117) as a therapeutic …
Amplitude Healthcare Acquisition Corporation Announces
WebShape Therapeutics Inc. Biotechnology Research Seattle, Washington 6,644 followers The future of programmable RNA Medicines WebUnited States securities and exchange commission logo October 22, 2024 William Lis Chief Executive Officer Jasper Therapeutics, Inc. 2200 Bridge Pkwy Suite #102 Redwood … nottingham trent university course dates
Jasper Therapeutics Launches with $35 Million Series A ... - BioSpace
WebAcum 2 zile · The Trade: Jasper Therapeutics, Inc. (NASDAQ:JSPR) 10% owner Gary Rieschel acquired a total 2,666,666 shares an average price of $1.50. To acquire these … WebJasper Therapeutics’ management team is composed of experienced biopharma industry veterans with extensive track records in drug development and commercialization. With … REDWOOD CITY, Calif. , March 31, 2024 (GLOBE NEWSWIRE) -- Jasper … Jasper is a clinical stage biotechnology company focused on the development … About Jasper. Jasper is a clinical-stage biotechnology company developing … Addressing Limitations Of Transplant Grafts. Allogeneic or autologous gene … Jasper Therapeutics, Inc. is a clinical-stage biotechnology company developing … At Jasper Therapeutics, our goal is to bring curative hematopoietic stem cell … Dr. Zoltowski joined Jasper Therapeutics in April 2024 as Senior Vice President, … Get In Touch. Jasper Therapeutics, Inc. 2200 Bridge Pkwy Suite #102, Redwood … Web31 mar. 2024 · Jasper Therapeutics, Inc. (ehemals Amplitude Healthcare Acquisition Corporation) ist ein Biotechnologieunternehmen, das sich auf Therapien zur Transplantation hämatopoetischer Zellen konzentriert. Das Unternehmen hat Programme entwickelt, wie z.B. JSP191, einen monoklonalen Antikörper gegen CD117, der sich in der klinischen … nottingham trent university disability team